Skip to content
646 269 0773|alita@globalbioethics.org
facebooktwitterlinkedin
Global Bioethics Initiative (GBI) Logo Global Bioethics Initiative (GBI) Logo Global Bioethics Initiative (GBI) Logo
  • Home
  • About
  • Staff
    • Founders
    • Board of Directors
    • Advisory Board
    • Visiting Scholars
    • Student Interns
    • Volunteers
  • Events
  • Resources
    • COVID-19
  • Internships
  • Contact
  • Donate
Previous Next
  • View Larger Image surgical instruments

Creating a Market for Kidneys Has the Potential to Save Thousands of Lives

By Zoe Siegel

President Reagan signed the National Organ Transplant Act (NOTA) 30 years ago. It was hoped that NOTA would end organ shortages by instituting legal guidelines for the transplantation of organs. However, approximately 30 Americans are removed from waiting lists every day because they become too sick to receive transplants or because they perish.

One possible solution to this problem lies in implementing the European model of presumed consent in the United States. Unfortunately, many experts believe that transitioning to this model will not do much in the way of solving the current shortage: as it stands, only 1% of deceased individuals are qualified to donate their organs, and of this small percentage, 75% already do so voluntarily.

In an interview with Dr. Sally Satel, a resident scholar at the American Enterprise Institute, Professor Keith Humphrey inquired about her suggestion for providing incentives to kidney donors. She proposes a system in which the government or a specific charity would provide a variety of rewards such as retirement benefits, an income tax credit, or a gift to the donor’s charity of choice in exchange for organ donation. Donors would be given six months to contemplate their decisions to donate; this grace period would help make sure the agreements are informed. She further hypothesizes that offering incentives to potential donors will not affect the number of altruistic donations. If implemented, she believes that her proposed model could eliminate waiting lists for kidneys in the next five years.

Read the full article here.

By Admin@gbi|2020-04-09T23:53:32+00:00October 21st, 2014|News-Articles|0 Comments

Share This Story, Choose Your Platform!

facebooktwitterlinkedinreddittumblrpinterestvkEmail

About the Author: Admin@gbi

Avatar

Related Posts

  • Call for Applications! Bioethics of AI: The Intersection of AI and Medicine” Online Winter School December 16-21, 2024
    Call for Applications! Bioethics of AI: The Intersection of AI and Medicine” Online Winter School December 16-21, 2024
    Gallery

    Call for Applications! Bioethics of AI: The Intersection of AI and Medicine” Online Winter School December 16-21, 2024

  • AI Ethics: Why it matters! by Adarsh Srivastava, PGDISAD, Head of Data & Analytics Quality Assurance at Roche Diagnostics
    AI Ethics: Why it matters! by Adarsh Srivastava, PGDISAD, Head of Data & Analytics Quality Assurance at Roche Diagnostics
    Gallery

    AI Ethics: Why it matters! by Adarsh Srivastava, PGDISAD, Head of Data & Analytics Quality Assurance at Roche Diagnostics

  • A Unique, Eye-opening experience: A physician’s perspective by Rola Itani, MD
    A Unique, Eye-opening experience: A physician’s perspective by Rola Itani, MD
    Gallery

    A Unique, Eye-opening experience: A physician’s perspective by Rola Itani, MD

  • Jonathan D. Moreno Ph.D. Keynote Speaker
    Jonathan D. Moreno Ph.D. Keynote Speaker
    Gallery

    Jonathan D. Moreno Ph.D. Keynote Speaker

  • Jeanne F. Loring Ph.D. Keynote Speaker
    Jeanne F. Loring Ph.D. Keynote Speaker
    Gallery

    Jeanne F. Loring Ph.D. Keynote Speaker

Copyright 2012 - 2020 Global Bioethics | All Rights Reserved | Powered by Global Innovation Consortium
facebooktwitterlinkedin
Toggle Sliding Bar Area